
Neobanking in 2025: Which Players Are Disrupting the Market
In 2025, neobanks are no longer the “new kids” in finance; they are established digital-first institutions reshaping how people interact

In 2025, neobanks are no longer the “new kids” in finance; they are established digital-first institutions reshaping how people interact

2025 wasn’t a simple comeback year for fintech capital, it was a selection year. After years of froth, investors reset

From chaos to clarity: why compliance-first fintechs will own the next decade. When the Rules Change Mid-Flight Imagine you’re piloting

“Cure-grade cells, without the wait.” The greatest limitation of autologous CAR-T therapies has been cost and time: each patient’s cells

Medical breakthroughs thrive in ecosystems that pair innovation with oversight. NOK Therapeutics’ pioneering autologous NK-cell therapy, clear of lymphodepletion, marks

Introduction Cancer therapies are often out of reach. NÖK Therapeutics is bringing a fintech-style mindset to biotech—making high-impact therapies more

In a twist that feels almost dystopian, two of the world’s most trusted job platforms—Glassdoor and Indeed—have laid off over

In the quiet depths of the ocean, a storm is brewing not of waves, but of policy. The European Union

Introduction: When Hustle Culture Crosses the Line In the high-stakes world of fintech startups—where innovation races against burn rates and

When Crypto Wealth Becomes a Passport Problem In a world increasingly shaped by digital assets, President Donald Trump’s sweeping travel